REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 212 filers reported holding REATA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.78 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $747,000 | -19.2% | 5,177 | +14.4% | 0.44% | +18.1% |
| Q4 2019 | $925,000 | -2.6% | 4,525 | -61.7% | 0.37% | -19.9% |
| Q3 2019 | $950,000 | -53.9% | 11,827 | -45.9% | 0.46% | -47.3% |
| Q2 2019 | $2,062,000 | -10.8% | 21,857 | -19.2% | 0.88% | -14.3% |
| Q1 2019 | $2,312,000 | +74.9% | 27,055 | +14.8% | 1.02% | +41.3% |
| Q4 2018 | $1,322,000 | -41.2% | 23,567 | -14.4% | 0.72% | -20.6% |
| Q3 2018 | $2,250,000 | – | 27,521 | – | 0.91% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 2,896,901 | $291,457,000 | 32.14% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 46,646 | $4,693,000 | 5.31% |
| Ikarian Capital, LLC | 471,400 | $47,423,000 | 3.34% |
| Duquesne Family Office | 695,033 | $69,927,000 | 2.27% |
| Camber Capital Management LP | 685,000 | $68,918,000 | 2.12% |
| LBJ Family Wealth Advisors, Ltd. | 30,359 | $3,054,000 | 1.82% |
| MADDEN SECURITIES Corp | 33,127 | $3,333,000 | 1.80% |
| Biondo Investment Advisors, LLC | 104,120 | $10,475,000 | 1.80% |
| Tolleson Wealth Management, Inc. | 60,750 | $6,112,000 | 1.73% |
| Keel Point, LLC | 97,074 | $9,767,000 | 1.26% |